Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. [electronic resource]
Producer: 20010308Description: 121-9 p. digitalISSN:- 0167-594X
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Biomarkers
- Brain Neoplasms -- drug therapy
- Cell Division -- drug effects
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Cranial Irradiation
- Cyclophosphamide -- analogs & derivatives
- Cytarabine -- administration & dosage
- Disease Progression
- Female
- GTP-Binding Proteins -- biosynthesis
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes -- drug effects
- Genes, bcl-2 -- drug effects
- Glioblastoma -- drug therapy
- Humans
- Ki-67 Antigen -- biosynthesis
- Life Tables
- Lomustine -- therapeutic use
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplastic Stem Cells -- drug effects
- Nimustine -- administration & dosage
- Protein Glutamine gamma Glutamyltransferase 2
- Proto-Oncogene Proteins c-bcl-2 -- biosynthesis
- Radiotherapy, Adjuvant
- Survival Analysis
- Teniposide -- administration & dosage
- Transglutaminases -- biosynthesis
- Tumor Suppressor Protein p53 -- biosynthesis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.